1.Pendred's Syndrome Associated with Asymmetrical Septal Hypertrophy & Severe Anemia in a Non-Treated 15-Year-Old.
Phil Soo OH ; Seong Seop KIM ; Jee Yeon MIN ; I Seok KANG ; Dong Kyu JIN ; Heung Jae LEE
Journal of Korean Society of Pediatric Endocrinology 1997;2(1):127-132
We report an extremely specific case of Pendred's syndrome, originally described with an association of thyroid organification defect and hearing impairment; normal-sized thyroid, severe hypothyroidism manifested by profoundly retarded physical and mental development, cardiomegaly and severe hypochromic & microcytic anemia associated with asymmetrical septal hypertrophy.
Adolescent*
;
Anemia*
;
Cardiomegaly
;
Hearing Loss
;
Humans
;
Hypertrophy*
;
Hypothyroidism
;
Thyroid Gland
2.Diagnostic value of fine needle aspiration of thyroid nodules.
Sang Seok LEE ; Sun Ho KIM ; Jong Kwan KIM ; Phil Seok OH ; Jung Kyu LIM ; Chin Duk HUH ; Jang Shin SOHN
Journal of Korean Society of Endocrinology 1991;6(2):150-156
No abstract available.
Biopsy, Fine-Needle*
;
Thyroid Gland*
;
Thyroid Nodule*
3.A Case of Nodular Condyloma Lata on the Lip Mucosa.
Mi Ri KIM ; Jae Hong KIM ; Yoon Seok OH ; Seung Phil HONG ; Hana BAK ; Sang Hoon LEE ; Sung Ku AHN
Korean Journal of Dermatology 2008;46(12):1648-1650
Condyloma lata is a common manifestation of secondary syphilis, but involvement of the lip mucosa is rare. Nodular lesions, especially solitary nodules, are uncommon manifestations of secondary syphilis, and only a few cases have been described. Failure to recognize condyloma lata of the lip mucosa may delay diagnosis and treatment. A 20-year-old man presented with a 4-month history of a solitary nodule on his upper lip mucosa. A diagnosis of condyloma lata was made on the basis of serologic tests for syphilis and pathological findings. We report an interesting case of condyloma lata on the upper lip mucosa that showed an unusual clinical manifestation of secondary syphilis.
Humans
;
Lip
;
Mucous Membrane
;
Serologic Tests
;
Syphilis
;
Young Adult
4.Effect of Cardiac Rehabilitation on Physiologic and Inflammatory Markers in Patients with Acute Myocardial Infarction.
Joon Hyung DOH ; Jin A CHOO ; Yong Hoon KIM ; Hye Lim OH ; Phil Ho KIM ; Seok Jin AHN ; Jeong Bae PARK ; Ji Dong SUNG ; Kyung Pyo HONG
Korean Circulation Journal 2004;34(8):820-827
BACKGROUND AND OBJECTIVES: here are several reports of cardiac rehabilitation (CR) having beneficial effects on the reduction of cardiovascular mortality and in the prevention of recurrent coronary events in patient with myocardial infarction (MI). An 8-week CR program was investigated to see if it affected the prognostic factors, such as inflammatory markers, after acute MI. SUBJECTS AND METHODS: 33 male and 5 female patients, with a mean age of 55+/-10 yrs, were consecutively assigned to the CR (n=19) and the control (n=19) groups three weeks after acute MI. The 8-week CR program consisted of life style modification and aerobic exercise training. At the baseline, and after 8 weeks, the symptom limited exercise test and peripheral blood sampling were performed to measure the physiologic capacity, the serum levels of high sensitive C-reactive protein (hs-CRP) and the plasma levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha. The interval changes of each parameter were compared between the two groups. RESULTS: The interval increments of the maximal oxygen uptake (14.3% vs. 10.6%, CR vs. control group, p=0.014), anaerobic threshold (18.8% vs. 7.0%, CR vs. control group, p=0.044) and exercise duration (9.4% vs. 3.1%, CR vs. control group, p=0.009) were larger in the CR than in the control group. The magnitudes of the interval changes in hs-CRP, IL-6 and TNF-alpha, as inflammatory markers, did not differ between the two groups (p>0.05). CONCLUSION: This 8-week CR program demonstrated an improved exercise capacity for MI patients, but a larger clinical trial, with modified exercise intensity and duration, will be necessary to detect any possible effect on the inflammatory markers.
Anaerobic Threshold
;
C-Reactive Protein
;
Exercise
;
Exercise Test
;
Female
;
Humans
;
Interleukin-6
;
Interleukins
;
Life Style
;
Male
;
Mortality
;
Myocardial Infarction*
;
Oxygen
;
Plasma
;
Rehabilitation*
;
Tumor Necrosis Factor-alpha
5.Identification of a novel mutation in a patient with pseudohypoparathyroidism type Ia.
Ye Seung LEE ; Hui Kwon KIM ; Hye Rim KIM ; Jong Yoon LEE ; Joong Wan CHOI ; Eun Ju BAE ; Phil Soo OH ; Won Il PARK ; Chang Seok KI ; Hong Jin LEE
Korean Journal of Pediatrics 2014;57(5):240-244
Pseudohypoparathyroidism type Ia (PHP Ia) is a disorder characterized by multiform hormonal resistance including parathyroid hormone (PTH) resistance and Albright hereditary osteodystrophy (AHO). It is caused by heterozygous inactivating mutations within the Gs alpha-encoding GNAS exons. A 9-year-old boy presented with clinical and laboratory abnormalities including hypocalcemia, hyperphosphatemia, PTH resistance, multihormone resistance and AHO (round face, short stature, obesity, brachydactyly and osteoma cutis) which were typical of PHP Ia. He had a history of repeated convulsive episodes that started from the age of 2 months. A cranial computed tomography scan showed bilateral calcifications in the basal ganglia and his intelligence quotient testing indicated mild mental retardation. Family history revealed that the patient's maternal relatives, including his grandmother and 2 of his mother's siblings, had features suggestive of AHO. Sequencing of the GNAS gene of the patient identified a heterozygous nonsense mutation within exon 11 (c.637 C>T). The C>T transversion results in an amino acid substitution from Gln to stop codon at codon 213 (p.Gln213*). To our knowledge, this is a novel mutation in GNAS.
Amino Acid Substitution
;
Basal Ganglia
;
Brachydactyly
;
Child
;
Codon
;
Codon, Nonsense
;
Codon, Terminator
;
Exons
;
Humans
;
Hyperphosphatemia
;
Hypocalcemia
;
Intellectual Disability
;
Intelligence
;
Male
;
Obesity
;
Osteoma
;
Parathyroid Hormone
;
Pseudohypoparathyroidism*
;
Siblings
6.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care
Young-Min KIM ; Kyung Woon JEUNG ; Won Young KIM ; Yoo Seok PARK ; Joo Suk OH ; Yeon Ho YOU ; Dong Hoon LEE ; Minjung Kathy CHAE ; Yoo Jin JEONG ; Min Chul KIM ; Eun Jin HA ; Kyoung Jin HWANG ; Won-Seok KIM ; Jae Myung LEE ; Kyoung-Chul CHA ; Sung Phil CHUNG ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S41-S64
7.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 5. Post-cardiac arrest care
Young-Min KIM ; Kyung Woon JEUNG ; Won Young KIM ; Yoo Seok PARK ; Joo Suk OH ; Yeon Ho YOU ; Dong Hoon LEE ; Minjung Kathy CHAE ; Yoo Jin JEONG ; Min Chul KIM ; Eun Jin HA ; Kyoung Jin HWANG ; Won-Seok KIM ; Jae Myung LEE ; Kyoung-Chul CHA ; Sung Phil CHUNG ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S41-S64
8.Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale
Jinse PARK ; Seong-Beom KOH ; Kyum-Yil KWON ; Sang Jin KIM ; Jae Woo KIM ; Joong-Seok KIM ; Kun-Woo PARK ; Jong Sam PAIK ; Young H. SOHN ; Jin-Young AHN ; Eungseok OH ; Jinyoung YOUN ; Ji-Young LEE ; Phil Hyu LEE ; Wooyoung JANG ; Han-Joon KIM ; Beom Seok JEON ; Sun Ju CHUNG ; Jin Whan CHO ; Sang-Myung CHEON ; Suk Yun KANG ; Mee Young PARK ; Seongho PARK ; Young Eun HUH ; Seok Jae KANG ; Hee-Tae KIM
Journal of Clinical Neurology 2021;17(3):501-501
9.Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale
Jinse PARK ; Seong-Beom KOH ; Kyum-Yil KWON ; Sang Jin KIM ; Jae Woo KIM ; Joong-Seok KIM ; Kun-Woo PARK ; Jong Sam PAIK ; Young H. SOHN ; Jin-Young AHN ; Eungseok OH ; Jinyoung YOUN ; Ji-Young LEE ; Phil Hyu LEE ; Wooyoung JANG ; Han-Joon KIM ; Beom Seok JEON ; Sun Ju CHUNG ; Jin Whan CHO ; Sang-Myung CHEON ; Suk Yun KANG ; Mee Young PARK ; Seongho PARK ; Young Eun HUH ; Seok Jae KANG ; Hee-Tae KIM
Journal of Clinical Neurology 2021;17(3):501-501
10.Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale
Jinse PARK ; Seong-Beom KOH ; Kyum-Yil KWON ; Sang Jin KIM ; Jae Woo KIM ; Joong-Seok KIM ; Kun-Woo PARK ; Jong Sam PAIK ; Young H. SOHN ; Jin-Young AHN ; Eungseok OH ; Jinyoung YOUN ; Ji-Young LEE ; Phil Hyu LEE ; Wooyoung JANG ; Han-Joon KIM ; Beom Seok JEON ; Sun Ju CHUNG ; Jin Whan CHO ; Sang-Myung CHEON ; Suk Yun KANG ; Mee Young PARK ; Seongho PARK ; Young Eun HUH ; Seok Jae KANG ; Hee-Tae KIM
Journal of Clinical Neurology 2020;16(4):633-645
Background:
and Purpose: The Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is widely used for estimating the symptoms of Parkinson’s disease. Translation and validation of the MDS-UPDRS is necessary for non-English speaking countries and regions. The aim of this study was to validate the Korean version of the MDS-UPDRS.
Methods:
Altogether, 362 patients in 19 centers were recruited for this study. We translated the MDS-UPDRS to Korean using the translation-back translation method and cognitive pretesting. We performed both confirmatory and exploratory factor analyses to validate the scale.We calculated the comparative fit index (CFI) for confirmatory factor analysis, and used unweighted least squares for exploratory factor analysis.
Results:
The CFI was higher than 0.90 for all parts of the scale. Exploratory factor analysis also showed that the Korean MDS-UPDRS has the same number of factors in each part as the English version.
Conclusions
The Korean MDS-UPDRS has the same overall structure as the English MDSUPDRS. Our translated scale can be designated as the official Korean MDS-UPDRS.